title: Thrombin down-regulates tissue factor pathway inhibitor expression in a PI3K/nuclear factor-κB-dependent manner in human pleural mesothelial cells.
abstract: Tissue factor pathway inhibitor (TFPI) is the primary inhibitor of the extrinsic coagulation cascade, and its expression is reported to be relatively stable. Various pathophysiologic agents have been shown to influence TFPI activity by regulating its expression or by modifying the protein. It is not clear how TFPI activity is regulated in normal physiology or in injury. Because thrombin and TFPI are locally elaborated in pleural injury, we sought to determine if thrombin could regulate TFPI in human pleural mesothelial cells (HPMCs). Thrombin significantly decreased TFPI mRNA and protein levels by > 70%. Thrombin-mediated down-regulation of TFPI promoted factor X activation by HPMCs. The ability of thrombin to significantly decrease TFPI mRNA and protein levels was maintained at nanomolar concentrations. Protease-activated receptor (PAR)-1, a mediator of thrombin signaling, is detectable in the mesothelium in human and murine pleural injury. PAR-1 silencing blocked thrombin-mediated decrements of TFPI in HPMCs. Thrombin activates PI3K/Akt and nuclear factor κB (NF-κB) signaling in HPMCs. Inhibition of PI3K (by PX-866) and NF-κB (by SN50) prevented thrombin-mediated TFPI mRNA and protein down-regulation. These are the first studies to demonstrate that thrombin decreases TFPI expression in HPMCs. Our findings demonstrate a novel mechanism by which thrombin regulates TFPI expression in HPMCs and promotes an unrestricted procoagulant response, and suggest that interactions between PI3K and NF-κB signaling pathways are linked in HPMCs and control TFPI expression. These findings raise the possibility that targeting this pathway could limit the ability of the mesothelium to support extravascular fibrin deposition and organization associated with pleural injury.
authors.affiliation: 1 Texas Lung Injury Institute and.
authors.forename: Ann
authors.initials: A
authors.lastname: Jeffers
authors.forename: Shuzi
authors.initials: S
authors.lastname: Owens
authors.forename: Kathleen
authors.initials: K
authors.lastname: Koenig
authors.forename: Brandon
authors.initials: B
authors.lastname: Quaid
authors.forename: Usha R
authors.initials: UR
authors.lastname: Pendurthi
authors.forename: Vijaya M
authors.initials: VM
authors.lastname: Rao
authors.forename: Steven
authors.initials: S
authors.lastname: Idell
authors.forename: Torry A
authors.initials: TA
authors.lastname: Tucker
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D015536:Down-Regulation; D004847:Epithelial Cells / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D008074:Lipoproteins / Q000235:genetics / Q000378:metabolism*; D008810:Mice, Inbred C57BL; D016328:NF-kappa B / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D010994:Pleura / Q000166:cytology; D044463:Receptor, PAR-1 / Q000378:metabolism; D013917:Thrombin / Q000502:physiology*
chemical_list: D008074:Lipoproteins; D016328:NF-kappa B; D044463:Receptor, PAR-1; C051928:lipoprotein-associated coagulation inhibitor; D019869:Phosphatidylinositol 3-Kinases; D013917:Thrombin
keywords: NF-κB; PI3K; pleural mesothelial cells; thrombin; tissue factor pathway inhibitor